"It is important to recognize that trisomy 21 does not receive enough attention from the scientific community. This is a unique book that brings to the medical community the vast work still needed to understand trisomy 21 and to improve outcomes of individuals with Down syndrome. The Trisomy 21 Research Society has done an excellent job supporting this publication and Mara Dierssen has achieved her goals well in editing this extremely important contribution." --Doody
1. Genetic and epigenetic pathways in Down syndrome: Insights to the brain and immune system from humans and mouse modelsY. Eugene Yu, Zhuo Xing, Catherine Do, Annie Pao, Eun Joon Lee, Sharon Krinsky-McHale, Wayne Silverman, Nicole Schupf and Benjamin Tycko2. Influence of allelic differences in Down syndromeRandall J. Roper, Laura Hawley and Charles R. Goodlett3. Modeling Down syndrome in cells: From stem cells to organoidsGillian Gough, Niamh L. O'Brien, Ivan Alic, Pollyanna A. Goh, Yeap Yee Jie, Jurgen Groet, Dean Nizetic and Aoife Murray4. Modeling Down syndrome in animals from the early stage to the 4.0 models and nextMaria del Mar Muñiz Moreno, Véronique Brault, Marie-Christine Birling, Guillaume Pavlovic and Yann Herault5. Mapping behavioral landscapes in Down syndrome animal models María Martínez de Lagrán6. Using mouse models to understand Alzheimer's disease mechanisms in the context of trisomy of chromosome 21Claudia Cannavo, Justin Tosh, Elizabeth M.C. Fisher and Frances K. Wiseman7. Focusing on cellular biomarkers: The endo-lysosomal pathway in Down syndromeAlexandra Botté and Marie-Claude Potier8. Translational validity and implications of pharmacotherapies in preclinical models of Down syndromeNoemí Rueda, Jesús Flórez, Mara Dierssen and Carmen Martínez-Cué9. Plasticity as a therapeutic target for improving cognition and behavior in Down syndromeCarmen Martínez-Cué and Mara Dierssen